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animal kingdom. In humans, it is still surrounded by much
controversy and myth. While many sex-specific differences
are remarkably obvious, others are subtle, complex, or
even puzzling. Psychological and socio-cultural factors can
also play a role by heavily influencing the perception of these
differences. Take pain, for instance.
The old tale that women can handle pain better than men,
perhaps because they endure labor pain, is far from being
backed up by science. In fact, numerous studies have re-
ported a higher prevalence of chronic pain and greater pain
sensitivity among women as compared to men (Mogil,
2012). It is likely that there is a psychological component to
this differential pain behavior, perhaps related to gender
role expectations and to the fact that women seem to be
more likely to seek health care than men. While these reports
convincingly show that women are more sensitive to pain
overall, the greatest scientific challenge is to untangle and
decode the various elements implicated in pain behavior
and the biological mechanisms underlying the differences
between sexes. This endeavor is further complicated by the
female hormonal cycle, which certainly impacts pain sensi-
tivity. It is therefore somewhat intuitive to think about a com-
mon pain circuit between sexes that would be further modu-
lated by circulating hormones. Indeed, this has been the
pervasive view in the pain research community.
The recent discovery that pain hypersensitivity in female
and male mice depends on different types of immune cells
challenges this notion and offers new insights as to why
men and women respond differently to pain (Sorge et al.,
2015). The jumping off point for this study was the finding
that inflammatory and neuropathic pain in male, but not fe-
male, mice depended on the Toll-like receptor 4 (TLR4)
(Sorge et al., 2011). The team led by Jeffrey Mogil and
Michael Salter now reports that the cell type where this re-
ceptor is expressed, the microglia, does not appear to be
involved in neuropathic pain processing in female mice.
Rather, females preferentially use an alternative pathway
dependent on resident T-lymphocytes. In this study, when
male mice were administered microglial inhibitors following
nerve injury, their pain sensitivity was significantly reduced,
while no improvement was seen in female mice (Sorge
et al., 2015). As microglia have been regarded as promising
targets to treat pain, these findings carry far-reaching clinical
implications for pain management and analgesic drug devel-
opment. Like all exciting discoveries, this study raises more
questions than it answers—the most obvious being how
these sex differences relate to disease and whether they
can help explain why pain-related and auto-immune disor-
ders, many of which involve T cell hyperactivity, are more
prevalent in women (Mogil, 2012). A large-scale gene regula-
tory study led by the laboratory of Howard Chang shed some
light on this conundrum (Qu et al., 2015). Here, the authors
mapped open chromatin sites in human immune T cells,
isolated from standard blood draws to generate a high-reso-lution regulome in a snapshot in time within a single individ-
ual. Gender was by far the most significant source of T cell
chromatin variability; hundreds of target genes were found
to be differentially regulated between male and female
T cells, including many autosomal genes associated with im-
mune function and autoimmune diseases.
Taken together, these two studies indicate a broader than
anticipated, and far more intricate, repertoire of immune-
related sex differences. Historically, medical research has
been conducted predominantly on males, and many studies
still fail to appreciate the importance of sexual dimorphism
both in experimental design and data interpretation. A pain-
ful, but valuable, lesson from this recent string of discoveries
is that equal representation of both sexes in pain research, or
in any biological discipline for that matter, is of utmost impor-
tance and that research performed mostly on males cannot
be applied to both sexes in a clinical setting.
With the growing appreciation that sex differences in med-
icine are extensive, there’s now little doubt that men and
women may require different strategies for the treatment of
pain and other conditions. As personalized medicine takes
political and scientific spotlight, hopefully sex and gender-
based medicine will follow.
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